---
title: "CYRX: Revenue grew 14%, adjusted EBITDA turned positive, and 2026 guidance rose"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304526842.md"
description: "Q3 revenue rose 14% YoY to $50.2 million, with commercial CGT revenue up 20% and adjusted EBITDA positive at $1.1 million. Full-year 2026 revenue guidance increased to $197 million–$199 million.Original document: CryoPort, Inc. [CYRX] SEC 8-K Current Report — Nov. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-11-05T21:21:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304526842.md)
  - [en](https://longbridge.com/en/news/304526842.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304526842.md)
generator: "portal-rs"
---

# CYRX: Revenue grew 14%, adjusted EBITDA turned positive, and 2026 guidance rose

Q3 revenue rose 14% YoY to $50.2 million, with commercial CGT revenue up 20% and adjusted EBITDA positive at $1.1 million. Full-year 2026 revenue guidance increased to $197 million–$199 million.

Original document: CryoPort, Inc. \[CYRX\] SEC 8-K Current Report — Nov. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [CYRX.US](https://longbridge.com/en/quote/CYRX.US.md)

## Related News & Research

- [CryoPort (NASDAQ:CYRX) Stock: Insider Daniel Hancock Sells 74,379 Shares](https://longbridge.com/en/news/305449778.md)
- [Cryoport (CYRX) Lifts 2026 Outlook Following Revenue Update As Fair Value Stays Just Behind](https://longbridge.com/en/news/304925527.md)
- [AI tech rout prompts US investors to rush into value stocks](https://longbridge.com/en/news/306321872.md)
- [AI solves 167-year-old maths problem, Anthropic researcher claims](https://longbridge.com/en/news/306318851.md)
- [‘Nobody Knows,’ Says Investor on Anthropic Stock](https://longbridge.com/en/news/306309262.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**